About ESCO
ESCO is the College of the European School of Oncology. It offers aspiring medical, radiation and surgical oncologists a structured educational pathway that spans their career from medical student through to taking on leadership responsibilities.
Enrolling in ESCO gives you access to advanced career resources and opportunities to build meaningful networks. The next phase of your career starts with ESCO - find out more about ESCO benefits or how to join!
Science
Direct
Free online subscription to the Health and Life Science section of ScienceDirect
ESCO
directory
Connect with our global network of ESCO Students and Faculty
ESCO
library
The latest published materials in oncology research and clinical practice
CTC
fellowship
Gain speciality knowledge and experience in a multidisciplinary clinical settings through short-term fellowships at a centre of excellence in Europe
Certificate
programme
Increasing clinical competence in the diagnosis and treatment of patients in Lymphoma, Breast and Lung cancer
ESCO
Mentorship
Access individual support and career development through shared knowledge and personal experiences
ESCO
Grant
Supporting clinical training, research, career development and educational opportunities outside ESO
e-ESO
team
Developing, promoting and participating in ESO’s distance learning programme
ESO events
Social Feeds
- Photos from ESO European School of Oncology's post 📢 Don’t miss tonight’s e-session on ‘’Highlights of ICML 2021’’.
Expert: Astrid Pavlovsky
Discussant: Wendy Osborne
⏰ 18:15
✅ CME accredited
📚 Some bacground reading
https://www.e-eso.net/sessions/2408
#esoncology #haemato-oncology #lymphoma #checkpointinhibitors - ESCO offers career insight and support that is tailored to your #oncology journey, with most resources available online!
That means you can manage your career at your own pace, anytime, anywhere. 🏖️🕶️
🎓ESCO enrolment/renewal is open for 2022
🔗https://bit.ly/2CGi27l - ESCO offers career insight and support that is tailored to your #oncology journey, with most resources available online!
That means you can manage your career at your own pace, anytime, anywhere. 🏖️🕶️
🎓#ESOcollege enrolment/renewal is open for 2022
🔗https://t.co/uYxUlCTHEO https://t.co/KX4LPdZ8Ka - Calling all #journalists who have an interest in #cancer & #oncology. ESO has funding available to help support journalists interested in reporting on this topic.
Submit your story proposal by 31st July for the chance of being selected. https://bit.ly/3vqtBWX - Calling all #journalists who have an interest in #cancer & #oncology. ESO has funding available to help support journalists interested in reporting on this topic. Submit your story proposal by 31st July for the chance of being selected. https://t.co/gpCIVt5lVb https://t.co/M0iHSbLPC3
- Your oncology career can take a lot of exciting directions 🗺️ R&D, Medical Affairs, Regulatory or even Marketing! 🥼✏️
🎓 ESCO can help you choose the right one for you!
Join us tonight, Dr Meinolf Linn presents Alternative Careers in ... - Your #oncology career can take a lot of exciting directions 🗺️ R&D, Medical Affairs, Regulatory or even Marketing! 🥼✏️
🎓ESCO can help you choose the right one for you!
Tonight Dr Meinolf Linn presents Alternative Careers in Oncology #ESOcollege
🔗https://t.co/7dUW8Md4p1... - So what if only a tiny fraction of cancer research is conducted in countries most in need of sustainable solutions? Cancer World's Swagata Yadavar talks to clinical and epidemiological researchers in Malaysia, India and Zambia about why this has to ...
- Tune in for tonight’s e-session on “#Immunotherapy in childhood ALL” at ⏰18:15 CEST.
Expert: Franco Locatelli
Discussant: Rupert Handgretinger
✅ PAEDIATRIC ONCOLOGY Pathway
https://t.co/kMnaPnw36p
#esoncology #pediatriconcology #immunotherapy #all #leukaemia #cancer #oncology https://t.co/YJWrmeYIxC - Tune in for tonight’s e-session on “Immunotherapy in childhood ALL” at ⏰18:15 CEST.
Don’t miss the chance to ask the experts during the e-session.
Expert: Franco Locatelli
Discussant: Rupert Handgretinger
✅ PAEDIATRIC ONCOLOGY Pathway
✅ CME Accredited
https://www.e-eso.net/sessions/2086
———
#esoncology ... - Lymph node evaluation prior to neoadjuvant chemotherapy Listen to "Lymph node evaluation prior to neoadjuvant chemotherapy" with Rosa Di Micco!
- Tune in for tonight’s e-session on “Nutritional screening, assessment” at ⏰18:15 CEST
Expert: Jann Arends
Discussant: Virpi Sulosaari
✅ CME Accredited
https://t.co/gWfZJ1ULPb
#esoncology #nutrition #nutritiononcology #nutritionincancer #cancer #oncology https://t.co/J4gXKBZ7bX - Photos from ESO European School of Oncology's post Tune in for tonight’s e-session on “Nutritional screening, assessment” at ⏰18:15 CEST.
❓Ask the experts❓
Expert: Jann Arends
Discussant: Virpi Sulosaari
✅ CME Accredited
https://www.e-eso.net/sessions/2413
———
#esoncology #nutrition #nutritiononcology #nutritionincancer #cancer #oncology #cancercare - More than 95% of ESCO students are eager to re-enrol! 🙋🏻♀️ Enrolment is now open for our 2022 events 🗓
Let's start planning the next exciting phase of your oncology career.
🎓Enrol in ESCO now or reenrol for next year!
... - More than 95% of ESCO students are eager to re-enrol! 🙋🏻♀️
Enrolment is now open for 2022
Let's start planning the next exciting phase of your #oncology career.
🎓Enrol in ESCO now or renew for next year! #ESOcollege
🔗https://t.co/uYxUlCTHEO https://t.co/dUZaquRzC1 - ESCO Enrolment Narmin When you're considering a specialisation, ESCO has the resources you need to make a confident decision.
Just ask our members, like Narmin Talibova. 🩺 Have you decided on a specialisation? Was it difficult to choose? Share with us below!👇
🎓ESCO ... - When you're considering a specialisation, ESCO has the resources you need to make a confident decision.
Just ask our members, like @TalibovaNarmin.🩺Have you decided on a specialisation? Let us know! 👇
🎓#ESOcollege enrolment/renewal is open for 2022
🔗https://t.co/uYxUlDbiwm https://t.co/8XeedKdk6i - Motion managment is key to provide patients with targeted and personalized treatments in #radiationoncology . Tune in for tonight’s #esession for an overview of “Motion management in radiation oncology”. ⏰18:15 CEST ➡️ https://t.co/FAal3r3dde #esoncology #cancercare #oncology https://t.co/IcqdrcP0eE
- Photos from ESO European School of Oncology's post Motion managment is key to provide patients with targeted and personalized treatments in radiation oncology.
Tune in for tonight’s e-session for an overview of “Motion management in radiation oncology”.
Expert: Jenny Bertholet
Discussant: Pierfrancesco Franco
⏰18:15 CEST
✅ CME accredited
... - Cancer of Unknown Primary (CUP) Listen to the new #e_eso podcast on "Cancer of Unknown Primary" with Nicholas Pavlidis!
- European Cancer Summit – 17-18 November, Brussels & Virtual | EONS - The European Oncology Nursing Society Every year, the European Cancer Organisation (E.C.O.) brings together leading oncology experts, experienced patient advocates, key opinion leaders, policy makers...
-
- Day 2 of our Baltic and Eurasia Masterclass in full swing.
All participants are now eligible to enrol in ESCO #ESOcollege giving them access to Mentorships, networking opportunities, fellowships and much more...
🎓#ESOcollege enrolment/renewal is open
🔗https://t.co/uYxUlCTHEO - Participants from this weekend's Masterclass are eligible to enrol in ESCO. 🎓 #ESOcollege
Find out more about the exclusive career development benefits on offer.
Enrolment/renewal for 2022 is now open
🔗https://t.co/uYxUlCTHEO - Another ESO - ESMO - European Society for Medical Oncology Masterclass in clinical oncology begins today, this time for those based in the Baltic and Eurasia region. Good luck everyone, we hope you learn lots and enjoy the experience #ESOexperience
- Photos from ESO European School of Oncology's post 📢 Don’t miss tonight’s e-session on ‘’Immunotherapy in upper GI tumours’’.
Expert: Elizabeth Smyth
Discussant: Sara De Dosso
⏰ 18:15
✅ CME accredited
📚 Some bacground reading
https://www.e-eso.net/sessions/2410
#esoncology #GIcancer #immunotherapy #cancertreatment #cancer#oncology - The pattern of spread of MPM poses unique challenges to a radiation oncologist. Since the disease most often is confined to the ipsilateral pleura, local control is the primary concern. However, treating the entire pleura requires a large radiation field, ...
Follow us